Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other most ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Albert K. Chin, MD, has spent over 35 years working in the field of medical technologies, having earned a great deal of ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.